Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
3.005
+0.005 (0.17%)
May 2, 2025, 4:00 PM EDT - Market closed
Protalix BioTherapeutics Employees
Protalix BioTherapeutics had 213 employees as of December 31, 2024. The number of employees increased by 5 or 2.40% compared to the previous year.
Employees
213
Change (1Y)
5
Growth (1Y)
2.40%
Revenue / Employee
$250,700
Profits / Employee
$13,765
Market Cap
234.10M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
PLX News
- 24 days ago - Protalix BioTherapeutics Is A Strong Buy With Increasing Revenues And A Promising Pipeline - Seeking Alpha
- 5 weeks ago - Protalix BioTherapeutics to Present at the iAccess Alpha Virtual Best Ideas Spring Conference 2025 - PRNewsWire
- 6 weeks ago - Protalix BioTherapeutics Says With Debt Fully Repaid, It's Well-Positioned To Execute Strategy Through 2025 And Beyond - Benzinga
- 6 weeks ago - Protalix BioTherapeutics, Inc. (PLX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Protalix BioTherapeutics Reports Fiscal Year 2024 Financial and Business Results - PRNewsWire
- 7 weeks ago - Protalix BioTherapeutics to Announce Fiscal Year 2024 Financial and Business Results on March 17, 2025 - PRNewsWire
- 3 months ago - Protalix BioTherapeutics to Participate in the 2025 BIO CEO & Investor Conference - PRNewsWire
- 4 months ago - Protalix BioTherapeutics Issues 2025 Letter to Stockholders - PRNewsWire